Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Collagen Market Worth $8.64 Billion by 2029 – Exclusive Report by Meticulous Research®

Published

on

Redding, California, Aug. 01, 2022 (GLOBE NEWSWIRE) — According to a new market research report titled, Collagen Market by Type (Gelatin, Collagen Peptide, and Native Collagen), Source (Porcine, Bovine, Marine, Chicken, and Sheep), and Application (Food & Beverage, Pharmaceuticals, Nutraceuticals, and Healthcare) – Global Forecasts to 2029’, in terms of value, the collagen market is expected to reach $8.64 billion by 2029, at a CAGR of 6.9% from 2022 to 2029. In terms of volume, the market is expected to reach 755.3 KT by 2029, at a CAGR of 5.1% from 2022 to 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5121

Collagen is the most abundant protein in the human body. At least 28 types of collagen relate to their source tissue in the body. Collagen types I and III coexist in skin and bone tissues, while collagen type II comes from cartilage, which makes up most of the protein content and coexists with glycosaminoglycans chondroitin sulfate and hyaluronic acid. Collagen type II is more valuable due to the scarcity of its source and unique molecular composition. Additionally, the predominant fibrous proteins in animals constitute a major structural component in the extracellular matrix of all multicellular animals, including sponges, invertebrates, and vertebrates. From a biomedical view, collagen plays important roles in development, wound healing, bones and joint health, platelet activation, and angiogenesis.

The major factors driving the collagen market are the growing use of collagen in food industries, the increasing inclination towards protein and nutricosmetics consumption, the increasing healthcare and technical applications, and the growing use of collagen-based biomaterials. In addition, the rise in per capita income opens untapped geographies, and the growing food processing industry provides significant opportunities to collagen manufacturers. On the other hand, dealing with the safety concern and improving the processing technology are the key challenges in this market. However, safety concerns, religious constraints, and the growing use of alternatives are restraining the growth of this market to some extent.

Impact of COVID-19 on the Global Collagen Market

The COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected over 100 countries (European Centre for Disease Prevention and Control). To control the spread of this disease and avoid related severe consequences, governments across the globe have announced partial or complete lockdown, which has majorly impacted many manufacturing and service industries, including collagen.

Per current independent scientific research dated 19th March 2020, the total number of NK and T cells was decreased or exhausted in COVID-19 patients. Importantly, in patients convalescing after therapy, the number of NK and T cells was restored. These results suggest that the functional exhaustion of cytotoxic lymphocytes is associated with SARS-CoV-2 (cause of COVID-19) infection. Hence, SARS-CoV-2 infection may break down antiviral immunity at an early stage.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5121

However, the ingestion of collagen peptides improves the number of NK cells and T cells and henceforth the immunity of humans. Immune competence decreases with age. It has been reported that the number of CD8+ CD28+ T cells correlates strongly with age because the number of these cells decreases with age. Ingestion of collagen peptides also helps build immunity amongst senior citizens, increasing the collagen demand.

Moreover, consumers’ interest in collagen-based products is growing in various applications, including food & beverage, nutraceutical supplements, cosmetics, and medical products. Consumers are particularly focusing on health and performance nutrition with the nutraceutical collagen. Thus, all these factors support the growth of the global collagen market.

The global collagen market is segmented based on type, source, application, and geography. The study also evaluates industry competitors and analyses the regional and country-level markets.

Based on type, the global collagen market is segmented into gelatin, collagen peptide, native collagen, and synthetic collagen. In 2022, the gelatin segment is expected to account for the largest share of the global collagen market. The large market share of this segment is attributed to the increased demand from the food and pharmaceutical industries, owing to its outstanding stabilizing features and binding characteristics. The recent trends in pharma drug deliveries include nutritional gummies, chewable soft capsules, and enteric capsules where the mass volume of gelatin is used. In addition, the growing usage of gelatin in photography, nutraceuticals, and cosmeceuticals is also contributing to its large adoption.

Based on source, the global collagen market is segmented into bovine, porcine, fish, chicken, sheep, and other animals. In 2022, the bovine segment is expected to account for the largest share of the global collagen market. The large share of this segment is attributed to its several health benefits such as skin health, tendon reinforcement, bone loss prevention, and relief from arthritis. This makes bovine collagen one of the widely used and accepted collagens. However, the fish collagen segment is expected to register the highest CAGR during the forecast period. The rapid growth of this segment is attributed to the rising fish production and growing cosmetic industry.

Quick Buy – Collagen Market Research Report: https://www.meticulousresearch.com/Checkout/63172835

Based on application, the global collagen market is segmented into food & beverage, pharmaceuticals, nutraceuticals, healthcare, cosmetics, and technical applications. In 2022, the food & beverage segment is expected to account for the largest share of the global collagen market. However, the nutraceuticals segment is expected to grow at the fastest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to the growing use of nutraceuticals for weight management across the globe.

Based on geography, in 2022, North America is expected to account for the largest share of the global collagen market. The major market share of the North American region is attributed to the huge consumption of cosmeceuticals and nutraceuticals, rise in research and development activities, well-established food and healthcare industry, and easy availability of raw materials. However, Asia-Pacific is expected to register the highest CAGR during the forecast period. The rapid growth of this region is mainly attributed to the increasing number of food manufacturers and the prevailing food processing industry, particularly in China and India; growing population; rising importance of nutrition and personal well-being; the steady pace of industrialization; growing personal care spending; and abundance of raw materials for collagen and gelatin.

Some of the key players operating in the collagen market are Rousselot (Netherlands), GELITA AG (Germany), Weishardt (France), Tessenderlo Group NV (Belgium), Nitta Gelatin Inc. (Japan), Lapi Gelatine S.p.a. (Italy), ITALGEL S.r.l. (Italy), Ewald-Gelatine GmbH (Germany), REINERT GRUPPE Ingredients GmbH (Germany), Trobas Gelatine B.V. (Netherlands), Gelnex (Brazil), Juncà Gelatines SL (Spain), HolistaCollTech Ltd. (Australia), Collagen Solutions Plc (U.K.), and Advanced BioMatrix, Inc. (U.S.).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/collagen-market-5121

Scope of the report

Collagen Market, by Type                 

  • Gelatin
  • Collagen Peptides (Hydrolyzed Collagen)
  • Native Collagen
  • Synthetic Collagen

Collagen Market, by Source

  • Bovine
  • Porcine
  • Fish
  • Chicken
  • Sheep
  • Other Sources

Collagen Market, by Application

  • Food & Beverage
    • Beverage
    • Confectionery
    • Dairy
    • Meat & Fish Products
    • Other Food & Beverage Applications (Sauces, Dressings, & Desserts)
  • Pharmaceuticals
    • Hard Gel Capsules
    • Soft Gel Capsules
    • Microencapsulation
  • Nutraceuticals
    • Sports Nutrition
    • Weight Management
  • Healthcare
    • Wound Dressing
    • Tissue Regeneration
    • Medical Implants
    • Cardiology
    • Research (Cell Culture & Cell Behavior)
    • Drug Delivery
  • Cosmetics
  • Technical Applications (Photography & Ballistic)

Collagen Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Malaysia
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America (RoLATAM)
  • Africa
  • Middle East

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5121

Related Reports:

Collagen Casings Market by Type (Edible, Non-Edible), Caliber (Small, Large), Application (Fresh Sausages, Processed Sausages (Pre-cooked, Smoked, Cured), End User (Food Service Providers, Food Retail), Distribution Channel – Global Forecast to 2028

https://www.meticulousresearch.com/product/collagen-casings-market-5220

Collagen Market by Product (Gelatin, Collagen Peptide, Native Collagen, Synthetic Collagen), Source (Porcine, Bovine, Chicken, Sheep, Other Sources), and Application (Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics, Healthcare) – Global Forecasts to 2027

https://www.meticulousresearch.com/product/collagen-market-5121

Collagen and Gelatin Market for Regenerative Medicine by Type, (Collagen and Gelatin), by Source, (Bovine, Porcine, Marine, and others), by Application, (Orthopedic, Wound Care, Cardiovascular, and others) – Global Forecast to 2022

https://www.meticulousresearch.com/product/collagen-gelatin-market-regenerative-medicine-3475

South East Asian Collagen Market by Product (Collagen Peptide and Gelatin), Source (Porcine, Bovine, Marine, Chicken, Sheep, and Other Animals), Application (Food and Beverages, Cosmetics, Nutraceuticals, Pharmaceuticals, Healthcare, and Technical) – Industry Forecast to 2023

https://www.meticulousresearch.com/product/south-east-asia-collagen-market-3634

Artificial Casings Market by Type (Collagen Casing, Cellulose Casing, Plastic Casing, Fibrous Casing, Vegetarian Casing), by Application (Animal Meat Sausages, Vegan Sausages), by Distribution Channel (Offline, Online) – Global Forecast to 2027

https://www.meticulousresearch.com/product/artificial-casings-market-5035

European Artificial Casings Market By Type (Collagen Casing, Cellulose Casing, Plastic Casing, Fibrous Casing, Value Added Casing, Textile Casing, Net Casing) – Industry Forecast to 2023

https://www.meticulousresearch.com/product/european-artificial-casings-market-4303

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected] 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/28/collagen-market-2029


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms

Published

on

enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms

MARKHAM, ON, April 25, 2024 /PRNewswire/ — Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.

SONIFI Health is a leading U.S. healthcare technology company based in Sioux Falls, South Dakota. The new partnership leverages and integrates Enghouse Video room systems technology to support SONIFI Health’s commitment to expanding telehealth applications and system optimizations in hospital settings.
Enghouse’s VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware solutions, has been fully integrated into SONIFI Health’s interactive TV systems. This integration provides up to 4K high-quality video conferencing, multi-party sessions and robust security features that ensure full compliance with healthcare regulations.
Enghouse Video offers an immersive telehealth platform to support collaborative interdisciplinary care, improved patient outcomes and cost savings. The platform is flexible and simple, delivering the reliability, interoperability, and scalability needed for today’s healthcare environment. A key strength of the partnership is its offering of back-end integrations like patient portals, medical devices, EMR, tele-sitting, remote patient observation and consultation.
“Hospitals can choose the telehealth partner that’s right for them, and we incorporate that solution with interactive TV,” said Brian Nido, SONIFI Health’s Vice President of Customer Success. “Using the hardware and systems they already have in patient rooms helps hospitals reduce costs and maximize the value of their existing investments, while benefiting both clinicians and patients.”
SONIFI Health and Enghouse Video continue to collaborate closely to further refine and enhance the telehealth solutions provided to healthcare facilities. This partnership reflects a shared commitment to leveraging technology to create smarter hospital rooms and improve patient care across the healthcare spectrum.
About Enghouse VideoEnghouse Video, part of the Enghouse Interactive division, is a subsidiary of Enghouse Systems Limited, a vertically focused software and services company traded on the Toronto Stock Exchange (TSX: ENGH). Through highly secure, scalable and flexible Cloud-based or On Prem services, we deliver one of the world’s highest quality and most innovative video platform to video-enable any application or idea. From advanced video conferencing and collaboration tools to state-of-art enterprise video management, Enghouse Video is a unique player in multiple markets, including telehealth. Learn more at www.enghousevideo.com, read our blog, or follow us on Twitter at @EnghouseVideo, on LinkedIn, and on Facebook.
About SONIFI HealthSONIFI Health provides market-leading interactive patient engagement technology proven to improve patient outcomes and staff productivity. The EHR-integrated platform is designed to enhance patient and family experiences while increasing staff satisfaction and organizations’ operational efficiencies. As part of SONIFI Solutions, Inc., the company annually supports more than 300 million end user experiences. Learn more at sonifihealth.com.
Enghouse Video Contact: Sylvain Awad, Director, Demand Generation, Enghouse Video, part of Enghouse Interactive Division, [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms-302126882.html

Continue Reading

Artificial Intelligence

Global Insurance Provider Selects 3CLogic to Streamline AI and Contact Center Capabilities with ServiceNow

Published

on

global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow

Multinational Insurance Broker to deploy 3CLogic’s solution with ServiceNow’s Financial Service Operations (FSO) platform to streamline customer experiences.
ROCKVILLE, Md., April 25, 2024 /PRNewswire/ — 3CLogic, the leading Conversational AI and Contact Center solution for ServiceNow®, today announced its selection by a global insurance provider to replace its existing contact center infrastructure as part of a larger CX transformation effort. The strategic decision is designed to complement the organization’s use of ServiviceNow’s Financial Services Operations (FSO) offering leveraged across a number of its existing product lines including Customer Warranty Claims, Roadside Assistance, and Home Warranties.

Serving millions of customers worldwide with innovative insurance and protective products, the organization required a solution that would enhance its recent investment in the ServiceNow platform as it works to transform its end-to-end customer service operations. The deployment will incorporate several of 3CLogic’s AI-powered capabilities purpose-built for ServiceNow, including Conversational AI, Speech Analytics, and AI Performance & Coaching, along with integrated call transcriptions, convenient 2-way SMS, and ServiceNow-centralized contact center reporting.
“We continue to see enterprises eager to complement their existing investment in digital platforms, such as ServiceNow, with contact center features purpose-built to extend the workflows and features they already have and use,” explains Matt Durkin, VP of Global Sales at 3CLogic. “It’s no secret that organizations are already juggling too many systems, often with overlapping capabilities, which impacts ROI and operational efficiency. We’re proud to offer an alternative approach that helps simplify the technology stack while optimizing the overall operational costs and outcomes.”
Recently named to Constellation Research’s 2024 Shortlist for Digital Customer Service and Support, 3CLogic has seen global adoption of its solution by leading enterprises in healthcare, manufacturing, travel, retail, higher education, finance, non-profits, and Managed Service Providers across five continents. As a ServiceNow-certified Technology and Build partner with offerings available for ServiceNow’s IT Service Management, Customer Workflows, HR Service Delivery, and Source-to-Pay solutions, the company will be unveiling its latest set of capabilities at ServiceNow’s annual Knowledge 2024 event this May in Las Vegas.
For more information, please contact [email protected].
About 3CLogic3CLogic transforms customer and employee experiences with its leading Cloud Contact Center and AI solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative features such as intelligent self-service, generative and Conversational AI, agent automation & coaching, and AI-powered sentiment analytics – all designed to lower operational costs, maximize ROI, and optimize each interaction across IT Service Desks, Customer Support, Sales or HR Services teams. For more information, please visit www.3clogic.com.
Logo – https://mma.prnewswire.com/media/2318845/3CLogic_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow-302127739.html

Continue Reading

Artificial Intelligence

ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO

Published

on

screenpoint-medical-leadership-transition:-pieter-kroese-confirmed-as-ceo

Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
NIJMEGEN, Netherlands, April 25, 2024 /PRNewswire/ — ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint’s commercial growth and success over the past 2 years.

 
 
The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint’s flagship Transpara software to support millions of scans a year.
“I am thrilled to lead ScreenPoint into its next phase of growth and innovation,” said Mr. Kroese. “I am deeply committed to building upon the strong foundation we have and continuing to work closely with our talented team to drive continued success. We are already expanding screening capacity and capability through proven reader support – we look forward to increasing our ability to support providers and women moving forward.”
Sir Michael Brady, Chairman of the Board at ScreenPoint Medical and a co-founder of the company, expressed enthusiasm about Pieter’s appointment, stating, “Pieter’s remarkable leadership qualities, coupled with his depth of knowledge of our product and industry, make him the perfect choice to lead ScreenPoint into the future. His strategic mindset and commitment to excellence align perfectly with our company mission of early breast cancer detection. Pieter has been an integral part of our growth to date and will provide seamless leadership through this transition into our next chapter for our customers, partners, and team.”
Author of “No Longer Radical” and over a hundred peer-reviewed publications on breast imaging, Dr. Rachel Brem is a Transpara user and ScreenPoint Board Member. Dr. Brem welcomed Mr. Kroese with the following: “Pieter has been an integral part of the ScreenPoint team for years. I am confident that his leadership will continue to deliver product excellence: earlier detection with outstanding reading workflow and improved patient outcomes. We continue to see these results from clinical sites all over the world, including many here in the United States. No other Breast AI solution has demonstrated the same results as Transpara, and I am confident that the team will continue to push on these frontiers under Pieter’s leadership.” 
The entire team at ScreenPoint extends its gratitude to Mark Koeniguer and wishes him every success in the future, while warmly welcoming Pieter Kroese into his new role as CEO.
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers.
See all the proof at: https://screenpoint-medical.com/evidence.
Photo: https://mma.prnewswire.com/media/2397831/Pieter_Kroese_CEO_ScreenPoint_Medical.jpgLogo: https://mma.prnewswire.com/media/1582198/ScreenPoint_Medical_Logo.jpg
 
 

View original content:https://www.prnewswire.co.uk/news-releases/screenpoint-medical-leadership-transition-pieter-kroese-confirmed-as-ceo-302127719.html

Continue Reading

Trending